Pharmaceutical Industry

CVS and Walgreens find themselves at the center of the abortion debate

Abigail Adcox · January 21, 2023 9:00 am

Infamous pharmaceutical executive Martin Shkreli, center, will go before a House panel.

FTC asks court to hold ‘pharma bro’ Martin Shkreli in contempt for failing to abide by orders

Brady Knox · January 21, 2023 3:42 am

Johnson & Johnson ends trial for HIV vaccine after data show it is ineffective

Abigail Adcox · January 18, 2023 8:12 pm

Florida Gov. Ron DeSantis speaks at the annual leadership meeting of the Republican Jewish Coalition, on Nov. 19, 2022, in Las Vegas.

DeSantis targets middlemen on drug prices

Abigail Adcox · January 14, 2023 9:00 am

Obese children should take weight-loss drugs, pediatrics group recommends

Abigail Adcox · January 9, 2023 2:56 pm

President Trump signed into law the FDA Reauthorization Act of 2017 on Friday. It reauthorizes a program in which drug and device makers pay the FDA a fee for every new product application, and the agency uses that money to hire more people and speed up approvals. (AP Photo/Andrew Harnik, File)

FDA approves new experimental Alzheimer’s drug

Abigail Adcox · January 6, 2023 7:16 pm

Median price of newly approved drugs topped $200,000 last year, analysis finds

Abigail Adcox · January 5, 2023 6:48 pm

Walgreen Co. will fill prescriptions at no upfront cost to some patients who don't have all the information they need for coverage received through the health care overhaul. (AP Photo/Keith Srakocic)

Walgreens and CVS plan to get certification to sell abortion pills

Brady Knox · January 5, 2023 6:00 am

Community & Family

Anti-abortion groups look to states and lawsuits to restrict access to abortion pills

Abigail Adcox · January 5, 2023 4:00 am

This Sept. 22, 2010 photo shows bottles of the abortion-inducing drug RU-486 in Des Moines, Iowa, which Planned Parenthood of the Heartland clinic doctors can remotely prescribe using a telemedicine terminal.

FDA to allow retail pharmacies to offer abortion pills

Abigail Adcox · January 4, 2023 2:22 pm

Drugmakers to raise prices of 350 drugs at start of 2023

Brady Knox · December 31, 2022 9:32 pm

President Trump signed into law the FDA Reauthorization Act of 2017 on Friday. It reauthorizes a program in which drug and device makers pay the FDA a fee for every new product application, and the agency uses that money to hire more people and speed up approvals. (AP Photo/Andrew Harnik, File)

House Dems fault FDA’s ‘atypical’ review process for Biogen’s Alzheimer’s drug

Abigail Adcox · December 29, 2022 8:50 pm